Puhlmann Markus has filed 4 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 150000 shares of Perspective Therapeutics, Inc. ($CATX) on March 02, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Perspective Therapeutics, Inc. | $CATX | Puhlmann Markus | Chief Medical Officer | A | Stock option (right to buy) | 150000 | $0.00 | 150,000.0000 | 74,337,990 | 9999.99% | 0.20% |
| March 3, 2025 | Perspective Therapeutics, Inc. | $CATX | Puhlmann Markus | Chief Medical Officer | A | Stock option (right to buy) | 165000 | $0.00 | 165,000.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Perspective Therapeutics, Inc. | $CATX | Puhlmann Markus | Chief Medical Officer | A | Stock option (right to buy) | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 24, 2024 | Perspective Therapeutics, Inc. | $CATX | Puhlmann Markus | Chief Medical Officer | P | Common Stock | 280000 | $0.50 | 1,375,425.0000 | 0 | 25.56% | 0.00% |